⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IONS News
Ionis Pharmaceuticals, Inc. Common Stock
FDA Approves High Dose Regimen of SPINRAZA® for Spinal Muscular Atrophy, Reflecting Progress Made Possible Through Decades of MDA Supported Research
globenewswire.com
BIIB
IONS
FDA Approves New High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy
globenewswire.com
IONS
BIIB
EMA validates indication extension application for Tryngolza® (olezarsen) for the treatment of severe hypertriglyceridemia (sHTG)
prnewswire.com
IONS
Kardigan Announces Positive Phase 2 Data for Tonlamarsen in Patients with Uncontrolled Hypertension Presented as Late-Breaker at ACC.26 and Simultaneously Published in JACC
businesswire.com
IONS
BMY
SNY
n-Lorem Publishes Commentary Offering Insight into Potential Commercialization Strategies for Nano-rare Medicines
businesswire.com
IONS
National Triglyceride Alliance Celebrates One Year of Impact and Recognizes National Triglycerides Day
prnewswire.com
IONS
ARWR
AMRN
Kardigan Announces Multiple Presentations at ACC.26 from its Late-Stage Portfolio of Personalized Cardiovascular Medicines
businesswire.com
IONS
SNY
BMY
Dallas Drive Leaps to Their First Win of the 2026 Pro Cheer League Season
prnewswire.com
IONS
Form 8-K
sec.gov
IONS
Ionis announces changes to Board of Directors
businesswire.com
IONS